Alan McShane
Keine laufenden Positionen mehr
Profil
Alan McShane served as the Director of the Intensive Care Unit at St. Vincent's University Hospital and as a Non-Executive Director at Sublimity Therapeutics Ltd.
He earned a doctorate degree from University College Dublin in 1976.
Ehemalige bekannte Positionen von Alan McShane
| Unternehmen | Position | Ende |
|---|---|---|
St. Vincent's University Hospital
 St. Vincent's University Hospital Hospital/Nursing ManagementHealth Services St. Vincent's University Hospital operates as a teaching hospital. It provides front line, acute, chronic and emergency care services. The company was founded by Mary Aikenhead in April, 1835 and is headquartered in Dublin, Ireland. | Corporate Officer/Principal | - |
Sublimity Therapeutics Ltd.
 Sublimity Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Sublimity Therapeutics Ltd. develops and manufactures pharmaceutical products. It engages in the development of gastrointestinal and immunological therapeutics. The firm’s lead product, CyCol, harnesses the powerful efficacy of the known immunosuppressive drug, cyclosporine in a safer format by targeting drug release towards the site of diseased tissue in the colon of patients with ulcerative colitis. Its other products include CyCron, AlloCol, CyLow, oral vaccines and oral peptides. The company was founded by Ivan Coulter in 2003 and is headquartered in Dublin, Ireland. | Direktor/Vorstandsmitglied | - |
Ausbildung von Alan McShane
| University College Dublin | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
St. Vincent's University Hospital
St. Vincent's University Hospital Hospital/Nursing ManagementHealth Services St. Vincent's University Hospital operates as a teaching hospital. It provides front line, acute, chronic and emergency care services. The company was founded by Mary Aikenhead in April, 1835 and is headquartered in Dublin, Ireland. | Health Services |
Sublimity Therapeutics Ltd.
Sublimity Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Sublimity Therapeutics Ltd. develops and manufactures pharmaceutical products. It engages in the development of gastrointestinal and immunological therapeutics. The firm’s lead product, CyCol, harnesses the powerful efficacy of the known immunosuppressive drug, cyclosporine in a safer format by targeting drug release towards the site of diseased tissue in the colon of patients with ulcerative colitis. Its other products include CyCron, AlloCol, CyLow, oral vaccines and oral peptides. The company was founded by Ivan Coulter in 2003 and is headquartered in Dublin, Ireland. | Health Technology |
